Current Status of Cancer Research in Adolescents—Problems of Children with Cancer

A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Hematology & Oncology".

Deadline for manuscript submissions: closed (25 May 2022) | Viewed by 18624

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Healthcare, State Academy of Applied Sciences in Jaroslaw, Czarnieckiego 16 Sreet, 37-500 Jarosław, Poland
Interests: paediatrics; oncology; cancer risk factors; assessment of life quality of cancer patients; social medicine problems
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The development of the civilization, technical, economic and industrial progress, apart from the obvious positive changes, has also caused the disturbance of the internal homeostasis of the organism, due to the constant influence of various harmful external factors, the occurrence of which is related to civilization development. Because of such changes, a person in every period of their life, from conception to adulthood, is exposed to the influence of carcinogenic factors that cause the malignant transformation of the cell, i.e., formation of cancer. Neoplastic diseases, classified as civilization diseases are the second, after poisoning, most common cause of death in children aged over one year, and it is expected that in the first decade of this century, one person out of 900 adults between 18 and 44 years of age will be recovered from childhood cancer. In Europe, there are approximately 15,000 new cases of cancer every year among children from 0 to 14 of age, and an additional 20,000 new cases among adolescents and young adults aged 15–24. There are countries where the incidence of childhood cancer exceeds 150 cases among 1 million children, e.g., Nigeria, Brazil, New Zealand, Sweden and Australia. It is estimated that in 2020, approximately 16,850 children and adolescents aged 0–19 will be diagnosed with cancer and 1730 will die from the disease. In the United States, it is estimated that approximately 11,050 new cases of cancer will be diagnosed in children from birth to 14 years of age in 2020, and approximately 1190 children are expected to die from the disease. Although cancer mortality rates in this age group fell by 65% between 1970 and 2016, cancer remains the leading cause of disease death in children. The most common types of cancer diagnosed in children 0–14 years of age are leukaemias, brain tumours and other tumours of the central nervous system, and lymphomas. The highest incidence of ALL is observed in the USA, Australia, Germany and Costa Rica and amounts to 32–44%, while in most European countries, it affects 23–29% of the population. The lowest incidence is observed in China (19.6%), India (11%), Japan (21%), New Zealand (12%) and Brazil (11.4%). The prevalence of ANLL is similar across geographies, except for Japan and some African countries where ANLL is more common than ALL. The incidence of cancer of the central nervous system in England and Wales is 16.21%, in France 16.85%, in Germany 20.0%, and in Hungary as much as 26.5%. There are differences in the incidence of different types of cancer depending on race. Ewing's sarcoma and testicular malignancies are mainly of the white race, Wilms' tumour is less common in Asia than in Europe and the United States, and more common in the black race. In turn, acute lymphoblastic leukaemia is diagnosed twice as often in white people than black people.

A child's cancer affects their entire family and is a source of chronic stress for a sick child, as well as for their parents and siblings. It deprives the feeling of security, introduces uncertainty, fear, and destabilizes the current life. It mobilizes the family, who must reconcile the treatment of the disease, frequent visits to the hospital with the hardships of everyday life. The emotional burden the family has to deal with is enormous. Families do not forget about the irreversibility and longevity of the disease, about the fact that the child will suffer physical and mental suffering, and is constantly accompanied by concern for the life and health of a loved one. At the same time, all everyday life becomes subordinate to illness. Goals, priorities, values, plans for the near and further future are changing. The family learns to function in new circumstances, to cope with difficulties, experience difficult emotions and conflicts. It has to reconcile the requirements of caring for a sick child with professional work, concern for finances, caring for healthy siblings and contacts with the surrounding social environment. This makes the cancer treatment process difficult, burdensome and sometimes even unacceptable for the whole family.

The purpose of this Special Issue in Children is to draw attention to the physical, psychological and social problems of both children with cancer and their families. We encourage you to submit research results, scientific thoughts and experiences.

Dr. Anna Lewandowska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • problems of children with cancer
  • the problem of families of children with cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (6 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

22 pages, 362 KiB  
Article
Needs, Barriers and Facilitators of Adolescents Participating in a Lifestyle Promotion Program in Oncology: Stakeholders, Adolescents and Parents’ Perspective
by Johanne Kerba, Catherine Demers, Véronique Bélanger, Mélanie Napartuk, Isabelle Bouchard, Caroline Meloche, Sophia Morel, Nicolas Prud’homme, Isabelle Gélinas, Johanne Higgins, Daniel Curnier, Serge Sultan, Caroline Laverdière, Daniel Sinnett and Valérie Marcil
Children 2022, 9(9), 1340; https://doi.org/10.3390/children9091340 - 1 Sep 2022
Cited by 1 | Viewed by 2327
Abstract
Treatments for adolescent cancer can cause debilitating side effects in the short- and long-term such as nausea and malnutrition but also cardiometabolic disturbances. Although the risk for cardiometabolic complications is greater for adolescents with cancer than younger ones, adolescents typically respond poorly to [...] Read more.
Treatments for adolescent cancer can cause debilitating side effects in the short- and long-term such as nausea and malnutrition but also cardiometabolic disturbances. Although the risk for cardiometabolic complications is greater for adolescents with cancer than younger ones, adolescents typically respond poorly to family-oriented health promotion programs. This study aims to assess the needs, barriers and facilitators to healthy lifestyle promotion interventions for adolescents with cancer and how to best adapt these interventions for them. Interviews were held with adolescents treated for cancer (n = 9) and parents (n = 6), focus groups were conducted with stakeholders working in oncology (n = 12) and self-report questionnaires were sent to stakeholders involved in a health promotion intervention (n = 6). At the time of interview, mean age of adolescent participants (40% female) was 17.0 ± 1.9 years (mean age at diagnosis: 14.6 ± 1.6 years). Verbatim and responses to questionnaires were coded and analyzed using qualitative methods. Stakeholder stated that adolescents with cancer need to access activities adapted to their age, to communicate with peers going through a similar experience, and to preserve their schooling and friendships. Barriers to intervention reported by adolescents, parents and stakeholders include lack of motivation, schedule conflicts, fatigue and treatment side effects. Some of the barriers mentioned by adolescents and parents include pain, post-surgery problems, school, physical deconditioning, and lack of time. Facilitators mentioned by adolescents and parents comprise trust in stakeholders’ expertise, personalized approaches, scheduling flexibility. Stakeholders recommended to build trust in the relationship, favoring non-moralizing teachings, adapt interventions to adolescents’ limited attention span and avoiding the use of long-term health benefits as a motivator. Full article
12 pages, 958 KiB  
Article
Assessment of Platelet Mitochondrial Respiration in a Pediatric Population: A Pilot Study in Healthy Children and Children with Acute Lymphoblastic Leukemia
by Theia Lelcu, Anca M. Bînă, Maria D. Dănilă, Călin M. Popoiu, Oana M. Aburel, Smaranda T. Arghirescu, Claudia Borza and Danina M. Muntean
Children 2021, 8(12), 1196; https://doi.org/10.3390/children8121196 - 17 Dec 2021
Cited by 6 | Viewed by 2549
Abstract
Characterization of mitochondrial respiration in peripheral blood cells has recently emerged as a potential biomarker for the assessment of the severity of hematological malignancies (HM) in adults. Whether changes in platelet respiratory function occur in children with or without HM it is unknown. [...] Read more.
Characterization of mitochondrial respiration in peripheral blood cells has recently emerged as a potential biomarker for the assessment of the severity of hematological malignancies (HM) in adults. Whether changes in platelet respiratory function occur in children with or without HM it is unknown. The present pilot study was double-aimed: (i) to investigate whether platelet respiration is age-dependent in non-HM children and (ii) to assess the platelet mitochondrial respiration in children with newly diagnosed acute lymphoblastic leukemia (ALL). Blood samples obtained from age-grouped children (10–11, 13–14 and 16–17 years) with non-HM and children with ALL (10–11 years) were used to isolate platelets via differential centrifugation. High-resolution respirometry studies of isolated platelets were performed according to a protocol adapted to evaluate complex I and II-supported respiration. An age-related decrease in respiration was observed in the non-HM pediatric population and had comparable values for the 13–14 and 16–17 years. groups. In children with ALL, a significant increase in C I-supported active respiration and decrease in maximal noncoupled respiration were found at the disease onset. In conclusion, in a pediatric population, platelet mitochondrial respiration is age-dependent. Platelet respiratory dysfunction occurs in children with newly-diagnosed ALL, an observation that warrants further investigation of this change as a disease biomarker. Full article
Show Figures

Figure 1

10 pages, 618 KiB  
Article
Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
by Ana de Lucio Delgado, Jose Antonio Villegas Rubio, Corsino Rey Galan, Belen Prieto García, Maria de los Reyes González Expósito and Gonzalo Solís Sánchez
Children 2021, 8(11), 1027; https://doi.org/10.3390/children8111027 - 9 Nov 2021
Cited by 3 | Viewed by 1794
Abstract
We investigated the kinetics of CRP, PCT, IL-6 and MR-proADM in a cohort of consecutive febrile patients with cancer in order to test the hypothesis that higher plasma concentrations and the absence of a rapid decrease in peak values would be associated with [...] Read more.
We investigated the kinetics of CRP, PCT, IL-6 and MR-proADM in a cohort of consecutive febrile patients with cancer in order to test the hypothesis that higher plasma concentrations and the absence of a rapid decrease in peak values would be associated with disease severity. (1) Method: A prospective descriptive and analytical study of patients with cancer and fever (≤18 years of age) at a University Hospital was carried out between January 2018 and December 2019. Information collected: sex, age, diagnosis, date and symptoms at diagnosis and medical history. The episodes were classified into three groups: bacterial infection, non-bacterial infection and systemic inflammatory response syndrome (SIRS). (2) Results: One hundred and thirty-four episodes were included. Bacterial infection criteria were met in 38 episodes. Biomarkers were measured at four different points: baseline, at 12–24 h, at 25–48 h and at 49–72 h. All the biomarkers evaluated decreased after the peak level was reached. IL-6 and MR-proADM showed a trend towards higher levels in the SIRS group although this rise was statistically significant only for IL-6 (p < 0.005). Bacterial infections more frequently presented values of PCT above the cut-off point (>0.5 ng/mL) at 12–24 h. (3) Conclusion: In our experience, IL-6 kinetics is faster than PCT kinetics and both are faster than CRP in patients with fever and cancer who present a good outcome. Patients with a good evolution show a rapid increase and decrease of PCT and particularly of IL-6 levels. Full article
Show Figures

Figure 1

Review

Jump to: Research, Other

12 pages, 3869 KiB  
Review
‘Teratoid’ Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma
by Consolato M. Sergi, Marta Rojas-Vasquez, Michelle Noga and Bryan Dicken
Children 2022, 9(4), 565; https://doi.org/10.3390/children9040565 - 15 Apr 2022
Cited by 1 | Viewed by 2597
Abstract
Liver neoplasms are quite rare in childhood. They often involve 6.7 cases per 10 million children aged 18 years or younger. Hepatoblastoma (HB) is the most frequent tumor, but this neoplasm’s rarity points essentially to the difficulty of performing biologic studies and large-scale [...] Read more.
Liver neoplasms are quite rare in childhood. They often involve 6.7 cases per 10 million children aged 18 years or younger. Hepatoblastoma (HB) is the most frequent tumor, but this neoplasm’s rarity points essentially to the difficulty of performing biologic studies and large-scale therapeutic trials. On the pathological ground, HB is separated into an entirely epithelial neoplasm or a mixed neoplasm with epithelial and mesenchymal components. This last category has been further subdivided into harboring teratoid features or not. The ‘teratoid’ HB includes a mixture of components with heterologous origin. The heterologous components include neuroectoderm, endoderm, or melanin-holding cells with or without mesenchymal components. The most important criterium for the teratoid component is neuroepithelium, melanin, and, more recently, a yolk-sac-like component and neuroendocrine components. The mesenchymal components include muscle, osteoid, and cartilage, which are most often observed mainly in ‘teratoid’ neoplasms. The teratoid component or mesenchymal components are diagnosed with biopsies. They appear more prominent after chemotherapy due to the response and shrinkage of epithelial elements and non- or low-responsive components of mixed HB. This review focuses on the clinical, radiological, and pathological findings of HB with teratoid features. Full article
Show Figures

Figure 1

11 pages, 257 KiB  
Review
Psychosexual Care of Adolescent and Young Adult (AYA) Cancer Survivors
by Laura Reinman, Helen L. Coons, Jenna Sopfe and Robert Casey
Children 2021, 8(11), 1058; https://doi.org/10.3390/children8111058 - 16 Nov 2021
Cited by 17 | Viewed by 3324
Abstract
Adolescent and young adult (AYA) survivors of cancer have diverse psychosocial and medical needs, including those related to fertility and sexual health. Much of the focus of care around issues such as fertility and sexual health tends to be filtered through a biomedical [...] Read more.
Adolescent and young adult (AYA) survivors of cancer have diverse psychosocial and medical needs, including those related to fertility and sexual health. Much of the focus of care around issues such as fertility and sexual health tends to be filtered through a biomedical lens. However, it is essential that health care providers assess and support AYA survivors using a biopsychosocial and contextual framework to ensure the most comprehensive and accurate understanding of AYA survivor needs, especially those related to psychosexual health. A trusting relationship between the multi-disciplinary medical team and the AYA survivor that allows for open discussion about the physical and psychosocial components of sexual health is key to providing best care and outcomes. Full article

Other

Jump to: Research, Review

16 pages, 1570 KiB  
Systematic Review
Parental Pesticide Exposure and Childhood Brain Cancer: A Systematic Review and Meta-Analysis Confirming the IARC/WHO Monographs on Some Organophosphate Insecticides and Herbicides
by Joseph Feulefack, Aiza Khan, Francesco Forastiere and Consolato M. Sergi
Children 2021, 8(12), 1096; https://doi.org/10.3390/children8121096 - 28 Nov 2021
Cited by 15 | Viewed by 4148
Abstract
Background: Brain tumors are the second most common neoplasm in the pediatric age. Pesticides may play an etiologic role, but literature results are conflicting. This review provides a systematic overview, meta-analysis, and IARC/WHO consideration of data on parental exposure to pesticides and childhood [...] Read more.
Background: Brain tumors are the second most common neoplasm in the pediatric age. Pesticides may play an etiologic role, but literature results are conflicting. This review provides a systematic overview, meta-analysis, and IARC/WHO consideration of data on parental exposure to pesticides and childhood brain tumors. Methods: We searched PubMed, SCOPUS, and Google Scholar for literature (1 January 1966–31 December 2020) that assessed childhood brain tumors and parental exposure to pesticides. We undertook a meta-analysis addressing prenatal exposure, exposure after birth, occupational exposure, and residential exposure. A total of 130 case-control investigations involving 43,598 individuals (18,198 cases and 25,400 controls) were included. Results: Prenatal exposure is associated with childhood brain tumors (odds ratio, OR = 1.32; 95% CI: 1.17–1.49; I2 = 41.1%). The same occurs after birth exposure (OR = 1.22; 95% CI: 1.03–1.45, I2 = 72.3%) and residential exposure to pesticides (OR = 1.31; 95% CI: 1.11–1.54, I2 = 67.2%). Parental occupational exposure is only marginally associated with CBT (OR = 1.17, 95% CI: 0.99–1.38, I2 = 67.0%). Conclusions: There is an association between CBT and parental pesticides exposure before childbirth, after birth, and residential exposure. It is in line with the IARC Monograph evaluating the carcinogenicity of diazinon, glyphosate, malathion, parathion, and tetrachlorvinphos. Full article
Show Figures

Figure 1

Back to TopTop